Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.6.6 appears, replacing the previous v3.6.5. This is a minor update to the page metadata and does not modify any study content.
    Difference
    0.0%
    Check dated 2026-09-01T19:48:00.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Removal of the Melanoma entry, the related topics header, and the MedlinePlus Genetics link from the related topics section, reducing cross-links to external topics.
    Difference
    0.1%
    Check dated 2026-08-25T20:58:21.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    Added Melanoma and related topics (MedlinePlus Genetics) and updated the revision to v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-11T19:38:03.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The melanoma entry and the related topics header (including MedlinePlus Genetics) were removed from the page's related topics area, reducing disease-specific navigation on this study record.
    Difference
    0.1%
    Check dated 2026-08-04T14:52:53.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    Melanoma is added as a primary topic, and a related topics reference (MedlinePlus Genetics) is included, expanding the page's topic coverage. The revision status is updated from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-28T12:15:31.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    Removed the 'Melanoma' condition label from the study details and deleted the MedlinePlus Genetics related topics entry, including the 'related topics' header; this changes how the condition is described on the page and reduces exposure to external related information.
    Difference
    0.1%
    Check dated 2026-07-21T11:42:13.000Z thumbnail image

Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.